Tuesday, August 4, 2026

Yoon Seok Yeol Sentenced to 30 Years: What This Means for South Korea’s Political Landscape?

Former President Yoon Suk Yeol sentenced to 30 years for treason and abuse of power related to a military operation against North Korea.

Crypto-friendly Kennedy Jr. Shakes Up U.S. Election with Blockchain Budget

Robert F. Kennedy Jr., an independent candidate...

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

Health

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.

Revolutionizing Stroke Treatment: JLK’s AI Solution in 22 Hospitals

JLK, a medical AI firm, initiates a large-scale clinical study on stroke AI imaging solutions across 22 hospitals in Korea.

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.
Latest

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

Can Kidney Transplant Improve Blood Disorders? New Study Reveals Surprising Results for Patients with Aplastic Anemia

A study shows kidney transplants can improve outcomes in patients with severe aplastic anemia and end-stage renal failure.

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Yuhan Corporation Partners with Huinno: A Game Changer for AI-Based ECG Monitoring in the U.S. Market

Yuhan Corporation partners with Huey No for a strategic agreement to enter the U.S. digital healthcare market.

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

Unlock Radiant Skin: LABSENN’s Calming Serum Offers Powerful Anti-Aging Benefits

HLB Peptide launches LABSENN, a derma-science brand featuring innovative peptide technology and the Peptide Calming Serum for sensitive skin.

2026 Senior Care Market: CareLabs’ Bold New Venture Explained

CareLabs CEO Lee Min-kyung announces plans to enter the senior care market, leveraging digital healthcare for growth and innovation.

Discover the Future of Skincare: Humedix Unveils Re2O ECM at Cosmoprof Bologna 2026

Humedix showcased its Elravie Cosmetic line at Cosmoprof Bologna 2026, featuring the innovative Re2O ECM skin booster for global expansion.

Wantech Targets U.S. Market Expansion at AAD 2026: Key Strategies Revealed

Wontech aims to expand in the U.S. by showcasing products at the AAD and hosting Wave Denver 2026 for healthcare partnerships.

How Will Korea’s New R&D-Linked Drug Pricing Impact the Pharma Industry in 2026?

The new drug pricing reform aims to boost R&D in the pharmaceutical industry, but raises concerns for smaller firms facing cash flow issues.

Facing Doctor Shortages, South Korea Mandates 10-Year Service for Selected Medical Students

South Korea plans a Local Physician System to tackle healthcare disparities, offering support for students who serve in underserved areas.

Lotte Biologics Wins CDMO Leadership Award… Validates “Quality Management”

Lotte Biologics wins "Best New or Relaunched CDMO" at the 2026 CDMO Leadership Awards, showcasing rapid growth and global recognition.

As South Korea Launches Integrated Care, Doctors Warn the System Isn’t Ready

The Korean Medical Association raises concerns about the implementation of "Integrated Care," citing infrastructure and compensation issues.

Doctor Sentenced to 4 Years for Illegally Selling Etomidate: A Shocking Case of Medical Misconduct

A South Korean doctor received a four-year prison sentence for illegally profiting $940,000 by administering etomidate for sleep treatments.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.